Clinical Trials

Drug Resistance Prediction Tools – Review
Tech & Innovation Drug Resistance Prediction Tools – Review

The ever-evolving battle against bowel cancer has encountered a formidable challenge: drug resistance. Bowel cancer, one of the most common cancers in the U.K., affects over 44,000 individuals annually, pushing scientists to devise new tools for predicting how this cancer can evolve against

Can Personalized Diets Revolutionize Food Sensitivity Research?
Research & Development Can Personalized Diets Revolutionize Food Sensitivity Research?

Personalized diets are emerging as a beacon of hope in the complex world of food sensitivity research, offering potential solutions to a pervasive and intricate problem. Food sensitivities, distinct from well-known allergies, are linked to immune responses involving IgA and IgG antibodies. These

Are Patient-Friendly Drug Formulations the Future of Cancer Care?
Management & Regulatory Are Patient-Friendly Drug Formulations the Future of Cancer Care?

The field of cancer treatment has witnessed significant innovations, especially in the formulation of drugs designed to ease patient administration. The European Medicines Agency's endorsement of zanubrutinib tablets, Brukinsa's newer form, highlights an essential shift toward treatments that

Can Chromosomal Changes Drive Major Evolutionary Shifts?
Research & Development Can Chromosomal Changes Drive Major Evolutionary Shifts?

The question of whether chromosomal changes can be a catalyst for major evolutionary shifts is becoming increasingly pertinent in contemporary evolutionary biology discourse. Major evolutionary shifts, often referred to as macromutations, describe significant transformations in an organism's

Will Arthur Kuan Lead New Breakthroughs in Pancreatic Cancer?
Research & Development Will Arthur Kuan Lead New Breakthroughs in Pancreatic Cancer?

Pancreatic cancer remains a formidable challenge in the medical field, with its survival rates trailing behind those of many other cancers despite advances in treatment options. The Lustgarten Foundation, recognized as the leading private funder of pancreatic cancer research worldwide, is committed

Boosting Intracerebral Hemorrhage Research Through Better Diagnosis
Research & Development Boosting Intracerebral Hemorrhage Research Through Better Diagnosis

Intracerebral hemorrhage (ICH) stands as one of the most challenging and under-investigated types of stroke, demanding urgent attention to improve patient outcomes and advance clinical practices. Unlike ischemic strokes, which have been extensively researched and are widely recognized for their

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later